Sandbox29: Difference between revisions

Student (talk | contribs)
Student (talk | contribs)
No edit summary
 
(5 intermediate revisions by the same user not shown)
Line 6: Line 6:
Created by Lori Mathis
Created by Lori Mathis


1eve is a protein that is a drug used to prevent Alzheimer disease. The <scene name='Sandbox29/1eve/1'>overall structure</scene> of 1EVE contains 2 types of amphipathic elements; 15 <scene name='Sandbox29/Evebeta/1'>beta sheets</scene> and 16 <scene name='Sandbox29/Evealpha/1'>alpha helices</scene>.  1eve is a fairly standard molecule in the sense that the
<scene name='Sandbox29/Hydrophobic/1'>hydrophic</scene> aspects of the protein are well-maintained on the inside, while the hydrophillic portions are around the outside. 1eve has an active name called Acetylcholinesterase, which has a ligand called Aricept. There is an
<scene name='Sandbox29/Active_site/1'>active site</scene> in the middle of the molecule.  1eve is considered an AChE inhibitor, in which it has a high affinity for. The overall protein itself was created by a Japanese corporation called the Eisai Company.


This is a placeholder text to help you get started in
{{STRUCTURE_1eve |  PDB=1eve |  SCENE=  }}
placing a Jmol applet on your page. At any time, click
"Show Preview" at the bottom of this page to see how it goes.
 
 
 
<scene name='Sandbox29/1eve/1'>TextToBeDisplayed</scene>


<scene name='Sandbox29/1eve11/2'>TextToBeDisplayed</scene>


Replace the PDB id (use lowercase!) after the STRUCTURE_ and after PDB= to load
Reference to the Proteopedia pages dedicated to 1EVE, contributors are Eran Hodis, Joel L. Sussman, OCA, Wayne Decatur
and display another structure.
 
{{STRUCTURE_1eve |  PDB=1eve  |  SCENE=  }}

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Student